Application

18169361 · SUBSTITUTED 2,4-DIOXOTETRAHYDROPYRIMIDINES AS INTERMEDIATES IN THE SYNTHESIS OF BRUTON'S TYROSINE KINASE INHIBITORS

Filed 2023-02-15 · Granted · Patent 12441733 (2025-10-14) The official file ↗The patent and its PDF ↗ · Art unit 1624 · Examiner Douglas M Willis Typical · CPC C07D 239/22 · Novartis AG · NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

14.6 mo

to disposition 31.9 mo

Statutes raised

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.